M. Guvakova

发表

Insulin-like growth factors control cell migration in health and disease.

M. Guvakova, 2007, The international journal of biochemistry & cell biology.

Type I insulin-like growth factor receptor function in breast cancer

L. Sciacca, E. Surmacz, R. Nicosia, 1998, Breast Cancer Research and Treatment.

Insulin-like Growth Factor I Controls Adhesion Strength Mediated by α5β1 Integrins in Motile Carcinoma Cells

D. Boettiger, M. Guvakova, L. Lynch, 2004 .

Cellular pharmacology and protein binding of phosphoromonothioate and phosphorodithioate oligodeoxynucleotides: a comparative study.

M. Caruthers, J. Tonkinson, L. Yakubov, 1994, Antisense research and development.

Induction of fascin spikes in breast cancer cells by activation of the insulin-like growth factor-I receptor.

Josephine C. Adams, D. Boettiger, M. Guvakova, 2002, The international journal of biochemistry & cell biology.

High frequency of tumour cell reversion to non-tumorigenic phenotype.

Y. Lavrovsky, V. Lavrovsky, M. Guvakova, 1992, European journal of cancer.

The g3mclass is a practical software for multiclass classification on biomarkers

Serguei Sokol, M. Guvakova, 2022, Scientific Reports.

SHC–α5β1 Integrin Interactions Regulate Breast Cancer Cell Adhesion and Motility

S. Andò, E. Surmacz, D. Sisci, 1999 .

Phosphorothioate Oligodeoxynucleotides Bind to Basic Fibroblast Growth Factor, Inhibit Its Binding to Cell Surface Receptors, and Remove It from Low Affinity Binding Sites on Extracellular Matrix (*)

C. Stein, J. Tonkinson, I. Vlodavsky, 1995, The Journal of Biological Chemistry.

Rap2A Is Upregulated in Invasive Cells Dissected from Follicular Thyroid Cancer

D. Fraker, I. Prabakaran, Robert Lewis, 2011, Journal of thyroid research.

Ras-related protein 1 and the insulin-like growth factor type I receptor are associated with risk of progression in patients diagnosed with carcinoma in situ

D. Fraker, M. Feldman, N. Mitra, 2011, Breast Cancer Research and Treatment.

The activated insulin-like growth factor I receptor induces depolarization in breast epithelial cells characterized by actin filament disassembly and tyrosine dephosphorylation of FAK, Cas, and paxillin.

E. Surmacz, M. Guvakova, 1999, Experimental cell research.

Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.

E. Surmacz, M. Guvakova, 1997, Cancer research.

The small GTPase Rap1 promotes cell movement rather than stabilizes adhesion in epithelial cells responding to insulin-like growth factor I.

N. Kushnir, I. Prabakaran, M. Guvakova, 2014, The Biochemical journal.

Gaussian mixture models for probabilistic classification of breast cancer.

Paul J. L. Zhang, I. Prabakaran, M. Guvakova, 2019, Cancer research.

Functional role of α-actinin, PI 3-kinase and MEK1/2 in insulin-like growth factor I receptor kinase regulated motility of human breast carcinoma cells

Josephine C. Adams, D. Boettiger, M. Guvakova, 2002, Journal of Cell Science.

CDH2/N-cadherin and early diagnosis of invasion in patients with ductal carcinoma in situ

Paul J. L. Zhang, J. Tchou, I. Prabakaran, 2020, Breast Cancer Research and Treatment.

Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells.

E. Surmacz, M A Guvakova, E Surmacz, 1997, Experimental cell research.

Differential roles of IRS‐1 and SHC signaling pathways in breast cancer cells

M. Prisco, E. Surmacz, M. Guvakova, 1997, International journal of cancer.

Vav2 protein overexpression marks and may predict the aggressive subtype of ductal carcinoma in situ

D. Fraker, YunQing Jiang, N. Mitra, 2014, Biomarker Research.

Insulin receptor substrate 1 is a target for the pure antiestrogen ICI 182,780 in breast cancer cells

S. Andò, D. Sisci, E. Surmacz, 1999, International journal of cancer.

Vav2 protein overexpression marks and may predict the aggressive subtype of ductal carcinoma in situ

D. Fraker, YunQing Jiang, N. Mitra, 2014, Biomarker Research.

Automated Classification of Breast Cancer Across the Spectrum of ERBB2 Expression Focusing on Heterogeneous Tumors With Low Human Epidermal Growth Factor Receptor 2 Expression.

M. Guvakova, 2023, JCO clinical cancer informatics.

SHC-alpha5beta1 integrin interactions regulate breast cancer cell adhesion and motility.

S. Andò, E. Surmacz, D. Sisci, 1999, Experimental cell research.